(Q43570292)

24 November 2017

A model for analyzing the cost of the main clinical events after lung transplantation (English)

1 reference

24 November 2017

1 reference

Sharples LD

1

1 reference

24 November 2017

Taylor GJ

2

1 reference

24 November 2017

Karnon J

3

1 reference

24 November 2017

Caine N

4

1 reference

24 November 2017

Buxton M

5

1 reference

24 November 2017

McNeil K

6

1 reference

24 November 2017

Wallwork J

7

1 reference

24 November 2017

1 April 2001

1 reference

The Journal of Heart and Lung Transplantation

24 November 2017

1 reference

24 November 2017

20

1 reference

24 November 2017

4

1 reference

24 November 2017

474-482

1 reference

The economics of transplantation

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

A model for analyzing the cost of main clinical events after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

Economic costs of expanded criteria donors in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

An economic analysis of kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

A study of the quality of life and cost-utility of renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

Lifetime costs of lung transplantation: estimation of incremental costs

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

Pharmaco-economic study of FK 506 (Prograf) and cyclosporine A Neoral in cadaveric renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

A cost-effectiveness analysis of OKT3 induction therapy in cadaveric kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

The impact of immunosuppressive regimens on the cost of liver transplantation--results from the U.S. FK506 multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

[Immunosuppression with tacrolimus (FK 506) and cyclosporin A for preventing graft rejection after liver transplantation. Retrospective evaluation of medical costs based on the FG-O157 Study in 224 patients (Germany)]

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

Technology assessment of the Dutch Lung Transplantation Program.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

New immunosuppressive regimens in lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report--1999

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900251-5

7 January 2021

10.1016/S1053-2498(00)00251-5

Identifiers

DOI

1 reference

24 November 2017

1 reference